Sharda Cropchem Limited (BOM:538666)
1,250.95
-1.45 (-0.12%)
At close: Feb 13, 2026
Sharda Cropchem Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 50,312 | 43,199 | 31,630 | 40,452 | 35,798 | 23,956 |
Revenue | 50,312 | 43,199 | 31,630 | 40,452 | 35,798 | 23,956 |
Revenue Growth (YoY) | 32.28% | 36.57% | -21.81% | 13.00% | 49.43% | 19.60% |
Cost of Revenue | 33,675 | 30,286 | 23,429 | 28,612 | 25,004 | 16,364 |
Gross Profit | 16,637 | 12,913 | 8,201 | 11,839 | 10,794 | 7,592 |
Selling, General & Admin | 895.92 | 796.63 | 587.8 | 553.35 | 488.89 | 419.02 |
Other Operating Expenses | 6,859 | 5,292 | 4,307 | 4,598 | 3,014 | 2,590 |
Operating Expenses | 10,849 | 8,836 | 7,566 | 7,632 | 5,956 | 4,714 |
Operating Income | 5,788 | 4,077 | 635.21 | 4,207 | 4,838 | 2,879 |
Interest Expense | -16.97 | -21.06 | -36.19 | -45.1 | -22.13 | -27.72 |
Interest & Investment Income | 63.07 | 63.07 | 45.4 | 49.03 | 64.54 | 86.82 |
Currency Exchange Gain (Loss) | 730.14 | -179 | -3.86 | - | -164.57 | 198.86 |
Other Non Operating Income (Expenses) | 761.25 | 349.07 | 339.28 | 174.65 | 12.61 | 22.78 |
EBT Excluding Unusual Items | 7,325 | 4,289 | 979.84 | 4,386 | 4,728 | 3,159 |
Impairment of Goodwill | - | - | - | - | -4.33 | - |
Gain (Loss) on Sale of Investments | 223.68 | 147.84 | 39.96 | 20.32 | 62.72 | 110.59 |
Gain (Loss) on Sale of Assets | 0.2 | 0.2 | - | 0.55 | - | 0.03 |
Asset Writedown | -680.83 | -680.83 | -348.64 | -119.41 | -292.31 | -383.22 |
Other Unusual Items | 26.86 | 26.86 | 47.56 | 20.37 | 148.35 | 207.9 |
Pretax Income | 6,895 | 3,783 | 718.72 | 4,307 | 4,642 | 3,095 |
Income Tax Expense | 1,237 | 739.21 | 399.65 | 887.62 | 1,150 | 802.37 |
Earnings From Continuing Operations | 5,659 | 3,044 | 319.06 | 3,420 | 3,493 | 2,292 |
Minority Interest in Earnings | -0.83 | -0.39 | -0.23 | -0.23 | -0.24 | -0.44 |
Net Income | 5,658 | 3,044 | 318.83 | 3,420 | 3,493 | 2,292 |
Net Income to Common | 5,658 | 3,044 | 318.83 | 3,420 | 3,493 | 2,292 |
Net Income Growth | 131.62% | 854.67% | -90.68% | -2.09% | 52.40% | 39.18% |
Shares Outstanding (Basic) | 90 | 90 | 90 | 90 | 90 | 90 |
Shares Outstanding (Diluted) | 90 | 90 | 90 | 90 | 90 | 90 |
EPS (Basic) | 62.73 | 33.74 | 3.53 | 37.90 | 38.71 | 25.40 |
EPS (Diluted) | 62.73 | 33.74 | 3.53 | 37.90 | 38.71 | 25.40 |
EPS Growth | 131.78% | 854.67% | -90.68% | -2.09% | 52.40% | 39.18% |
Free Cash Flow | - | 6,035 | 3,408 | 3,276 | 2,668 | 2,463 |
Free Cash Flow Per Share | - | 66.89 | 37.78 | 36.31 | 29.57 | 27.30 |
Dividend Per Share | 12.000 | 9.000 | 3.000 | 6.000 | 6.000 | 5.000 |
Dividend Growth | - | 200.00% | -50.00% | - | 20.00% | 25.00% |
Gross Margin | 33.07% | 29.89% | 25.93% | 29.27% | 30.15% | 31.69% |
Operating Margin | 11.50% | 9.44% | 2.01% | 10.40% | 13.51% | 12.02% |
Profit Margin | 11.25% | 7.05% | 1.01% | 8.45% | 9.76% | 9.57% |
Free Cash Flow Margin | - | 13.97% | 10.78% | 8.10% | 7.45% | 10.28% |
EBITDA | 8,520 | 6,752 | 3,233 | 6,610 | 7,242 | 4,537 |
EBITDA Margin | 16.93% | 15.63% | 10.22% | 16.34% | 20.23% | 18.94% |
D&A For EBITDA | 2,732 | 2,675 | 2,598 | 2,403 | 2,405 | 1,658 |
EBIT | 5,788 | 4,077 | 635.21 | 4,207 | 4,838 | 2,879 |
EBIT Margin | 11.50% | 9.44% | 2.01% | 10.40% | 13.51% | 12.02% |
Effective Tax Rate | 17.93% | 19.54% | 55.61% | 20.61% | 24.76% | 25.93% |
Revenue as Reported | 51,395 | 43,794 | 32,228 | 40,854 | 36,086 | 24,415 |
Advertising Expenses | - | 244.19 | 134.24 | 78 | 24.05 | 23.44 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.